Evidence map›Paper›PMID 34362875›Full record

ArticleCell death discovery2021

Correction: TRIB2 desensitizes ferroptosis via βTrCP-mediated TFRC ubiquitiantion in liver cancer cells.

Susu Guo, Yuxin Chen, Xiangfei Xue, Yueyue Yang, Yikun Wang, Shiyu Qiu, Jiangtao Cui, Xiao Zhang, Lifang Ma, Yongxia Qiao and 1 more

Open access · goldAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Cell death discovery, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Susu Guo *Department of Clinical Laboratory, Shanghai Tenth People's Hospital, Tongji University, Shanghai, 200072, China.
Yuxin Chen *Department of Clinical Laboratory, West China Second University Hospital, Sichuan University, Sichuan, 610041, China.
Xiangfei XueDepartment of Clinical Laboratory, Shanghai Tenth People's Hospital, Tongji University, Shanghai, 200072, China.
Yueyue YangDepartment of Clinical Laboratory, Shanghai Tenth People's Hospital, Tongji University, Shanghai, 200072, China.
Yikun WangShanghai Institute of Thoracic Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, China.
Shiyu QiuShanghai Institute of Thoracic Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, China.
Jiangtao CuiShanghai Institute of Thoracic Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, China.
Xiao ZhangShanghai Institute of Thoracic Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, China.
Lifang MaShanghai Institute of Thoracic Oncology, Shanghai Chest Hospital, Shanghai Jiao Tong University, Shanghai, 200030, China.
Yongxia QiaoSchool of Public Health, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, China. yongxia.qiao@shsmu.edu.cn.
Jiayi WangDepartment of Clinical Laboratory, Shanghai Tenth People's Hospital, Tongji University, Shanghai, 200072, China. karajan2@163.com.ORCID http://orcid.org/0000-0003-1688-2864
Shanghai Jiao Tong University · CNTongji University · CNSichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID34362875
PMCPMC8346502
OpenAlexW3191227812

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.